Vericheck ddPCR Replication Competent AAV Kit

Adeno-associated virus (AAV) is frequently used in gene therapy but can potentially morph into a replication competent virus (RCV), posing safety risks. Regulatory guidelines recommend extensive testing to detect RCV presence. However, the current cell culture-based method is slow, taking up to 45 days. Bio-Rad's Vericheck ddPCR RCAAV Kit provides a quicker, more cost-effective, specific, and fully validated solution for AAV testing.